We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
RPS12
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • METABOLIC
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • METABOLIC

  • RPS12
PATHOLOGY GLIOMA Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
ANTIBODIES
AND
VALIDATION
Dictionary
Glioma
Human pathology
Glioma
GLIOMA - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

Read more
RPS12 is not prognostic in glioma


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

Read more
: 699.36
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

Read more
: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
3-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
3-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average FPKM 642.7
Number of samples 153
Samples
Sample Description FPKM
TCGA-06-2569-01A 24 years, female, black or african american, alive, 13 days 3149.2
TCGA-14-0871-01A 75 years, female, white, dead, 880 days 2173.0
TCGA-14-1829-01A 57 years, male, black or african american, alive, 218 days 1586.3
TCGA-02-0055-01A 62 years, female, white, dead, 76 days 1545.4
TCGA-27-2521-01A 34 years, male, white, dead, 510 days 1472.9
TCGA-06-0139-01A 40 years, male, white, dead, 362 days 1438.6
TCGA-32-5222-01A 66 years, male, white, dead, 585 days 1332.6
TCGA-12-5295-01A 60 years, female, white, dead, 454 days 1330.8
TCGA-06-0138-01A 43 years, male, white, dead, 737 days 1306.8
TCGA-27-1831-01A 66 years, male, white, dead, 505 days 1258.3
TCGA-14-0817-01A 69 years, female, white, dead, 164 days 1241.4
TCGA-02-2483-01A 43 years, male, asian, alive, 466 days 1144.7
TCGA-28-5218-01A 63 years, male, white, dead, 157 days 1115.6
TCGA-06-0238-01A 46 years, male, white, dead, 405 days 1107.5
TCGA-06-0744-01A 67 years, male, white, dead, 1426 days 1095.7
TCGA-19-4065-01A 36 years, male, white, alive, 214 days 1051.9
TCGA-14-1823-01A 58 years, female, white, dead, 543 days 1001.0
TCGA-32-1982-01A 76 years, female, white, dead, 142 days 998.9
TCGA-02-2486-01A 64 years, male, white, dead, 618 days 994.4
TCGA-14-2554-01A 52 years, female, white, dead, 532 days 979.6
TCGA-12-0616-01A 36 years, female, white, dead, 448 days 977.5
TCGA-26-5133-01A 59 years, male, white, alive, 452 days 926.1
TCGA-06-5417-01A 45 years, female, white, alive, 155 days 901.5
TCGA-06-0219-01A 67 years, male, white, dead, 22 days 876.7
TCGA-12-0821-01A 62 years, male, white, dead, 323 days 865.0
TCGA-12-3652-01A 60 years, male, white, dead, 1062 days 860.2
TCGA-06-0745-01A 59 years, male, white, dead, 239 days 860.1
TCGA-06-0749-01A 50 years, male, black or african american, dead, 82 days 857.2
TCGA-06-5416-01A 23 years, female, white, alive, 204 days 853.9
TCGA-06-2570-01A 21 years, female, white, alive, 958 days 828.5
TCGA-06-0210-01A 72 years, female, white, dead, 225 days 813.5
TCGA-06-0178-01A 39 years, male, white, dead, 2681 days 812.4
TCGA-06-5412-01A 78 years, female, white, dead, 138 days 794.4
TCGA-06-0686-01A 53 years, male, white, dead, 432 days 785.5
TCGA-76-4928-01B 85 years, female, white, dead, 94 days 772.9
TCGA-26-1442-01A 43 years, male, white, alive, 953 days 759.2
TCGA-02-2485-01A 53 years, male, black or african american, alive, 470 days 748.2
TCGA-06-0132-01A 49 years, male, white, dead, 771 days 739.5
TCGA-06-5418-01A 75 years, female, white, dead, 83 days 737.4
TCGA-41-5651-01A 59 years, female, black or african american, dead, 460 days 736.1
TCGA-28-5213-01A 72 years, male, white, alive, 951 days 731.5
TCGA-06-0156-01A 57 years, male, white, dead, 178 days 722.1
TCGA-06-2563-01A 72 years, female, white, alive, 932 days 701.1
TCGA-06-0645-01A 56 years, female, white, dead, 175 days 697.7
TCGA-28-2513-01A 69 years, female, white, alive, 222 days 683.3
TCGA-06-0130-01A 54 years, male, white, dead, 394 days 680.0
TCGA-06-0190-01A 62 years, male, white, dead, 317 days 676.9
TCGA-27-2524-01A 56 years, male, white, dead, 231 days 674.4
TCGA-06-0141-01A 62 years, male, white, dead, 313 days 674.0
TCGA-06-5411-01A 51 years, male, white, dead, 254 days 668.2
TCGA-32-4213-01A 47 years, female, white, alive, 604 days 666.8
TCGA-06-5410-01A 72 years, female, white, dead, 108 days 666.2
TCGA-06-0649-01B 73 years, female, black or african american, dead, 64 days 658.0
TCGA-27-2528-01A 62 years, male, white, dead, 480 days 651.9
TCGA-28-5208-01A 52 years, male, white, dead, 544 days 651.8
TCGA-12-1597-01B 62 years, female, white, dead, 675 days 650.6
TCGA-06-2558-01A 75 years, female, white, dead, 380 days 643.3
TCGA-32-1980-01A 72 years, male, white, dead, 36 days 634.0
TCGA-28-5216-01A 52 years, male, white, alive, 415 days 629.3
TCGA-32-2634-01A 82 years, male, white, alive, 693 days 622.7
TCGA-12-3650-01A 46 years, male, white, dead, 333 days 618.0
TCGA-26-5132-01A 74 years, male, white, alive, 286 days 616.0
TCGA-06-0644-01A 71 years, male, black or african american, dead, 384 days 598.9
TCGA-76-4927-01A 58 years, male, white, dead, 535 days 584.5
TCGA-06-0168-01A 59 years, female, white, dead, 598 days 583.4
TCGA-28-5207-01A 71 years, male, white, dead, 343 days 582.2
TCGA-76-4932-01A 50 years, female, white, dead, 1458 days 580.5
TCGA-14-0781-01B 49 years, male, black or african american, dead, 29 days 578.0
TCGA-14-1825-01A 70 years, male, white, dead, 232 days 576.0
TCGA-06-0174-01A 54 years, male, white, dead, 98 days 575.7
TCGA-06-0747-01A 53 years, male, white, dead, 82 days 574.6
TCGA-41-3915-01A 48 years, male, white, dead, 360 days 572.5
TCGA-27-1830-01A 57 years, male, white, dead, 154 days 569.9
TCGA-06-5414-01A 61 years, male, white, alive, 273 days 559.2
TCGA-19-1787-01B 49 years, male, white, dead, 385 days 556.7
TCGA-19-2620-01A 70 years, male, white, dead, 148 days 555.9
TCGA-06-0211-01B 47 years, male, white, dead, 360 days 555.2
TCGA-06-0184-01A 63 years, male, white, dead, 2126 days 554.2
TCGA-26-5135-01A 72 years, female, white, dead, 270 days 546.6
TCGA-41-2571-01A 89 years, male, white, dead, 26 days 544.7
TCGA-28-2509-01A 77 years, female, white, alive, 145 days 540.2
TCGA-32-2616-01A 48 years, female, white, dead, 224 days 538.2
TCGA-27-1834-01A 56 years, male, white, dead, 1233 days 537.1
TCGA-32-2638-01A 67 years, male, white, dead, 766 days 533.8
TCGA-14-0789-01A 54 years, male, white, dead, 342 days 526.8
TCGA-06-5413-01A 67 years, male, white, alive, 268 days 520.3
TCGA-06-0743-01A 69 years, male, white, dead, 803 days 518.4
TCGA-06-0129-01A 30 years, male, asian, dead, 1024 days 512.4
TCGA-12-0618-01A 49 years, male, white, dead, 395 days 511.7
TCGA-12-0619-01A 60 years, male, white, dead, 1062 days 509.4
TCGA-16-0846-01A 85 years, male, white, dead, 119 days 508.7
TCGA-19-2625-01A 76 years, female, white, dead, 124 days 498.8
TCGA-28-5220-01A 67 years, male, white, dead, 388 days 497.2
TCGA-27-2523-01A 63 years, male, white, dead, 489 days 489.7
TCGA-06-2567-01A 65 years, male, white, dead, 133 days 480.9
TCGA-06-0882-01A 30 years, male, white, dead, 632 days 477.8
TCGA-08-0386-01A 74 years, male, white, dead, 548 days 470.8
TCGA-26-5136-01B 78 years, female, white, dead, 577 days 469.1
TCGA-14-1034-01A 60 years, female, dead, 485 days 464.7
TCGA-12-5299-01A 56 years, female, white, dead, 98 days 463.3
TCGA-06-5858-01A 45 years, female, white, alive, 187 days 458.5
TCGA-14-0787-01A 69 years, male, asian, dead, 68 days 456.8
TCGA-06-0750-01A 43 years, male, white, dead, 28 days 454.1
TCGA-32-2632-01A 80 years, male, white, dead, 269 days 450.2
TCGA-76-4926-01B 68 years, male, white, dead, 138 days 450.1
TCGA-27-2526-01A 79 years, female, white, dead, 87 days 448.5
TCGA-27-1837-01A 36 years, male, white, dead, 427 days 446.6
TCGA-15-1444-01A 21 years, male, white, dead, 1537 days 444.6
TCGA-32-2615-01A 62 years, male, white, dead, 485 days 443.0
TCGA-06-2557-01A 76 years, male, black or african american, dead, 33 days 442.8
TCGA-06-0125-01A 63 years, female, white, dead, 1448 days 442.3
TCGA-28-1753-01A 53 years, male, white, alive, 37 days 436.8
TCGA-06-2565-01A 59 years, male, asian, dead, 506 days 435.9
TCGA-06-2562-01A 81 years, male, white, dead, 382 days 435.8
TCGA-26-5139-01A 65 years, female, white, alive, 48 days 433.1
TCGA-19-1390-01A 63 years, female, white, dead, 772 days 424.8
TCGA-06-2559-01A 83 years, male, white, dead, 150 days 422.5
TCGA-26-5134-01A 74 years, male, white, alive, 167 days 419.1
TCGA-28-1747-01C 44 years, male, white, dead, 77 days 418.3
TCGA-06-0158-01A 73 years, male, white, dead, 329 days 412.9
TCGA-16-1045-01B 49 years, female, white, dead, 883 days 411.6
TCGA-28-2499-01A 59 years, male, white, dead, 95 days 407.8
TCGA-06-0878-01A 74 years, male, white, alive, 218 days 404.1
TCGA-06-0646-01A 61 years, male, white, dead, 175 days 403.5
TCGA-06-2564-01A 50 years, male, white, alive, 181 days 391.6
TCGA-32-1970-01A 59 years, male, white, dead, 468 days 388.1
TCGA-28-5215-01A 62 years, female, white, dead, 335 days 387.1
TCGA-28-2514-01A 45 years, male, asian, alive, 160 days 380.0
TCGA-19-5960-01A 56 years, male, white, dead, 455 days 379.4
TCGA-06-5856-01A 58 years, male, white, dead, 114 days 370.5
TCGA-14-0790-01B 64 years, female, white, dead, 419 days 370.2
TCGA-12-3653-01A 34 years, female, white, dead, 442 days 363.4
TCGA-27-2519-01A 48 years, male, white, dead, 550 days 358.7
TCGA-41-2572-01A 67 years, male, white, dead, 406 days 345.7
TCGA-27-1835-01A 53 years, female, white, dead, 648 days 340.3
TCGA-19-2629-01A 60 years, male, white, dead, 737 days 339.2
TCGA-02-0047-01A 78 years, male, white, dead, 448 days 334.6
TCGA-28-5204-01A 72 years, male, white, dead, 454 days 332.7
TCGA-15-0742-01A 65 years, male, white, dead, 419 days 331.2
TCGA-19-2624-01A 51 years, male, white, dead, 5 days 328.4
TCGA-06-5408-01A 54 years, female, white, dead, 357 days 316.5
TCGA-27-1832-01A 59 years, female, white, dead, 300 days 315.5
TCGA-76-4925-01A 76 years, male, white, dead, 146 days 297.2
TCGA-41-4097-01A 63 years, female, white, dead, 6 days 291.7
TCGA-06-2561-01A 53 years, female, white, dead, 537 days 287.5
TCGA-06-5859-01A 63 years, male, white, alive, 139 days 285.3
TCGA-06-1804-01A 81 years, female, white, dead, 414 days 268.9
TCGA-06-0157-01A 63 years, female, white, dead, 97 days 261.1
TCGA-76-4931-01A 70 years, female, white, dead, 279 days 255.8
TCGA-28-5209-01A 66 years, female, white, alive, 77 days 231.9
TCGA-76-4929-01A 76 years, female, white, dead, 111 days 226.0
TCGA-06-0187-01A 69 years, male, white, dead, 828 days 222.0
TCGA-19-2619-01A 55 years, female, black or african american, alive, 294 days 172.9
Show allShow less
GLIOMA - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.

Read more

Antibody HPA006124
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Click images for details

Contact

  • NEWS ARTICLES
  • PRESS ROOM
  • contact@proteinatlas.org

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.